Reference number : GC-2017-Q2-05029, amendment number : , agreement type : G, recipient legal name : Savage, Rose-Lynne (SignalChem Pharmaceuticals Inc), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Experience Awards, program name french : Bourses Expérience, program purpose english : nan, program purpose french : nan, agreement title english : Production of protein kinases & assay development for kinase drug discovery, agreement title french : Production of protein kinases & assay development for kinase drug discovery, agreement number : USRAI, agreement value : 4500.0, agreement start date : 2017-09-20, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada